The board of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced that the board of supervisors of the company received a resignation letter tendered by Ms. Huang Fangfang, resigning from her position as the supervisor of the company and the chairman of the Board of Supervisors due to adjustment of her work arrangement. The Board of Supervisors has approved the resignation of Ms. Huang. However, as the resignation of Ms. Huang will result in the number of members of the Board of Supervisors falling below the minimum requirement stipulated under the articles of association of the company, her resignation will take effect upon the appointment of a new Supervisor at the annual general meeting of the company to be held on 6 June 2019. The Board also announced that the Board of Supervisors has resolved to nominate Mr. Tang Jinlong as the shareholder representative Supervisor of the second session of the Board of Supervisors. His nomination is subject to the approval by the shareholders of the company at the AGM. Mr. Tang, joined the company in July 2001 as deputy head of the development department of the company. He was the head of development department of the company from June 2003 to July 2004 and chief engineer of the company from August 2004 to January 2008. Mr. Tang was the deputy general manager of Yidu HEC Biochemical Manufacturing Co., Ltd. from March 2006 to December 2010 and the factory manager of Hecheng factory from January 2008 to December 2010. Since June 2015, Mr. Tang is the director of HEC Pharm Co., Ltd. Since February 2018, Mr. Tang is the chairman and legal representative of YiChang HEC Biochemical API Co., Ltd. and the director of Yichang HEC Pharmaceutical Manufacturing Co., Ltd.